Your browser doesn't support javascript.
loading
Changes of CFTR functional measurements and clinical improvements in cystic fibrosis patients with non p.Gly551Asp gating mutations treated with ivacaftor.
Mesbahi, Myriam; Shteinberg, Michal; Wilschanski, Michael; Hatton, Aurelie; Nguyen-Khoa, Thao; Friedman, Hannah; Cohen, Michael; Escabasse, Virginie; Le Bourgeois, Muriel; Lucidi, Vicenzina; Sermet-Gaudelus, Isabelle; Bassinet, Laurence; Livnat, Galit.
Afiliação
  • Mesbahi M; INSERM U 1151, Service de Pneumo-Pédiatrie, Université Paris-Sorbonne, Paris, France.
  • Shteinberg M; Cystic Fibrosis Center, Carmel Medical Center, Haifa, Israel; Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Wilschanski M; Cystic Fibrosis Center, Hadassah-Hebrew University Medical Centre, Jerusalem, Israel.
  • Hatton A; INSERM U 1151, Service de Pneumo-Pédiatrie, Université Paris-Sorbonne, Paris, France.
  • Nguyen-Khoa T; INSERM U 1151, Service de Pneumo-Pédiatrie, Université Paris-Sorbonne, Paris, France.
  • Friedman H; Cystic Fibrosis Center, Hadassah-Hebrew University Medical Centre, Jerusalem, Israel.
  • Cohen M; Cystic Fibrosis Center, Hadassah-Hebrew University Medical Centre, Jerusalem, Israel.
  • Escabasse V; Service d'ORL, Centre Intercommunal de Créteil, Créteil, France.
  • Le Bourgeois M; INSERM U 1151, Service de Pneumo-Pédiatrie, Université Paris-Sorbonne, Paris, France.
  • Lucidi V; Cystic Fibrosis Center, Bambino Jesu Hospital, Roma, Italy.
  • Sermet-Gaudelus I; Cystic Fibrosis Center, Bambino Jesu Hospital, Roma, Italy. Electronic address: Isabelle.sermet@aphp.fr.
  • Bassinet L; Service de Pneumologie, Centre Intercommunal de Créteil, Créteil, France.
  • Livnat G; Cystic Fibrosis Center, Carmel Medical Center, Haifa, Israel; Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
J Cyst Fibros ; 16(1): 45-48, 2017 01.
Article em En | MEDLINE | ID: mdl-27659740

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cloretos / Quinolonas / Regulador de Condutância Transmembrana em Fibrose Cística / Fibrose Cística / Aminofenóis Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cloretos / Quinolonas / Regulador de Condutância Transmembrana em Fibrose Cística / Fibrose Cística / Aminofenóis Idioma: En Ano de publicação: 2017 Tipo de documento: Article